Drug · DIN 02470748
MVASI
100 MG/4 ML SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 1, 2019; first marketed August 1, 2019.
- Drug Identification Number (DIN)
- 02470748
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Bevacizumab L01FG01
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BEVACIZUMAB | 25 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 30, 2018: NOC 20799New Drug Submission (NDS)
Other DINs named MVASI
- DIN 02470756 · Marketed